Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125995732 | 12599573 | 2 | F | 20160605 | 20160907 | 20160727 | 20160914 | EXP | JP-GILEAD-2016-0218335 | GILEAD | 66.00 | YR | E | F | Y | 0.00000 | 20160914 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125995732 | 12599573 | 1 | PS | SOVALDI | SOFOSBUVIR | 1 | Oral | 400 MG, UNK | Y | 204671 | 400 | MG | TABLET | ||||||
| 125995732 | 12599573 | 2 | SS | COPEGUS | RIBAVIRIN | 1 | Oral | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125995732 | 12599573 | 1 | Hepatitis C |
| 125995732 | 12599573 | 2 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125995732 | 12599573 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125995732 | 12599573 | Arthralgia | |
| 125995732 | 12599573 | Back pain | |
| 125995732 | 12599573 | Pain in extremity | |
| 125995732 | 12599573 | Peripheral swelling | |
| 125995732 | 12599573 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125995732 | 12599573 | 1 | 20160602 | 20160611 | 0 | |
| 125995732 | 12599573 | 2 | 20160602 | 20160611 | 0 |